Obesity Prevention Grants in Australia: Funding Healthier Weight and Lifestyle

Two in three Australian adults are overweight or obese — and rates continue to rise. Excess weight is associated with type 2 diabetes, cardiovascular disease, some cancers, sleep apnoea, osteoarthritis, and mental health challenges. The economic cost exceeds $11 billion annually. Yet obesity prevention and treatment are chronically underfunded and politically contested. Grant funding supports research, community prevention programmes, clinical treatment, and the advocacy needed to address what is one of Australia's most significant but least supported health challenges.

Overweight and obesity in Australia

Scale

  • Approximately 67% of Australian adults are overweight or obese
  • Approximately 25% are obese (BMI 30+)
  • Childhood obesity: approximately 25-27% of children aged 5-17 are overweight or obese
  • Rates are rising despite decades of public awareness

Disparities

  • Rural and remote Australians: higher rates
  • Aboriginal and Torres Strait Islander Australians: higher rates and more severe complications
  • Low socioeconomic status: strongly associated with obesity
  • Pacific Islander communities: very high rates (genetic and cultural factors)

Health consequences

Excess weight is a risk factor for:
- Type 2 diabetes (obesity responsible for >80% of T2DM cases)
- Cardiovascular disease
- Some cancers (endometrial, bowel, breast, oesophageal, kidney)
- Obstructive sleep apnoea
- Non-alcoholic fatty liver disease
- Osteoarthritis (particularly knee)
- Mental health conditions

Why obesity is politically contested

Obesity sits at the intersection of individual responsibility and structural/environmental determinants. Approaches that emphasise individual willpower and blame individuals for weight are not only ineffective but harmful. Evidence points to the food environment, physical activity environment, sleep, stress, and genetics as primary drivers — far more powerful than individual choice.

Government obesity funding

Department of Health

National obesity strategy — limited and contested:
- Healthy Food Partnership
- Physical activity guidelines
- Sugar-sweetened beverage discussions (highly contested by industry)
- Bariatric surgery through the public hospital system (limited access)

NHMRC

Research grants for obesity biology, prevention, and treatment.

Medical Research Future Fund (MRFF)

Precision nutrition, metabolic research, and treatment innovation.

State health departments

  • Healthy eating programmes
  • Physical activity grants
  • School canteen policy
  • Urban planning and active transport

Philanthropic obesity funders

Heart Foundation

  • Healthy eating policy advocacy
  • Food environment research
  • Physical activity grants

Diabetes Australia

  • Obesity-diabetes prevention programmes
  • Weight management support

VicHealth

  • Food environment advocacy
  • Physical activity grants in Victoria
  • Built environment research

The Sax Institute

Population health research including obesity prevention.

The George Institute for Global Health

Food policy, salt reduction, and obesity prevention research.

Cancer Council

Cancer prevention — obesity-related cancer prevention.

Types of funded obesity prevention programmes

Childhood obesity prevention

  • School-based healthy eating education
  • Physical education improvement
  • School canteen policy and healthy food environments
  • Screen time and sedentary behaviour reduction
  • After-school active programme
  • Family-based childhood obesity programmes
  • Preschool and early childhood obesity prevention

Community-based prevention

  • Healthy communities programmes
  • Walking groups and active community programmes
  • Community gardens and food access
  • Neighbourhood physical activity environments (playgrounds, walking paths, bike lanes)

Food environment

  • Healthy food access in disadvantaged communities (food deserts)
  • Sugar-sweetened beverage advocacy
  • Food labelling (Health Star Rating)
  • Marketing of unhealthy food to children (advocacy for restrictions)
  • Workplace food environments

Clinical weight management

  • Bariatric surgery (severely limited public access — long waiting lists)
  • Intensive behavioural programmes
  • GLP-1 agonist medications (Ozempic and similar — transforming pharmacological treatment)
  • Multidisciplinary weight management clinics

Indigenous obesity prevention

  • Community-controlled healthy eating programmes
  • Traditional food revitalisation
  • Physical activity in remote communities
  • Two-way learning approaches (Western nutrition + traditional food knowledge)

Pacific Islander communities

Very high obesity rates — culturally adapted approaches:
- Culturally appropriate physical activity programmes
- Community-led healthy eating
- Addressing social and cultural roles of food

Sleep and stress

Emerging evidence on sleep and stress as obesity drivers:
- Sleep health promotion (especially for shift workers)
- Stress management integration in weight management

The GLP-1 revolution

GLP-1 agonist medications (semaglutide/Ozempic, tirzepatide/Mounjaro) have dramatically expanded pharmacological treatment options for obesity. This creates new funding questions:
- Access equity (expensive — not yet fully PBS-subsidised for obesity)
- Combination with behavioural support
- Long-term safety and maintenance
- Research into optimal use and selection

Grant application considerations

Structural vs. individual framing

Funders and evidence now strongly support structural approaches (food environment, built environment, policy) over individual behaviour change programmes alone. Applications that address systemic drivers of obesity rather than just individual willpower are more compelling.

Childhood priority

Childhood obesity prevention is a priority for many funders — habits formed in childhood persist, and intervening early is more effective than adult obesity treatment.

Equity focus

Rural, Indigenous, low-income, and Pacific Islander communities face the highest obesity burden and the least access to support. Equity-focused applications are compelling.

GLP-1 access

The new GLP-1 medications are transformative but expensive and inaccessible for many — applications addressing equitable access (particularly for high-burden communities) are timely.


Tahua's grants management platform supports public health funders and weight management organisations — with programme participant tracking, clinical outcome measurement, food environment data, and the reporting tools that help obesity prevention funders demonstrate their investment in healthier communities and reduced chronic disease burden.

Book a conversation with the Tahua team →